References
- Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365:579–87.
- Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010;340:c2096.
- The European Centre of Disease Prevention and Control (ECDC), Stockholm Sweden. Available at: http://www.rivm.nl/earss/ (accessed September 2013).
- Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999;281:517–23.
- Colodner R, Rock W, Chazan B, Keller N, Guy N, Sakran W, Raz R. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis 2004;23:163–7.
- Blumberg HM, Rimland D, Carroll DJ, Terry P, Wachsmuth IK. Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. J Infect Dis 1991;163:1279–85.
- Deshpande A, Pant C, Jain A, Fraser TG, Rolston DD. Do fluoroquinolones predispose patients to Clostridium difficile associated disease?A review of the evidence. Curr Med Res Opin 2008;24:329–33.
- Smittevernloven—håndbok. Bruk av antibiotika i sykehus (Infection control handbook. Inpatient use of antibiotics). Oslo: Statens Helsetilsyn; 2001.
- Lindbæk MR. Nasjonale faglige retningslinjer for antibiotikabruk i primærhelsetjenesten (National guidelines for antibiotic prescribing in primary care). Oslo: Helsedirektoratet; 2008. Available at: http://www.helsebiblioteket.no/microsite/Antibiotikaretningslinjer (accessed August 2013).
- Litleskare I, Blix HS, Rønning M. Antibiotikaforbruk i Norge (Antibiotic use in Norway, English summary). Tidsskr Nor Legeforen 2008;128:2324–9.
- NORM/NORM-VET 2010. Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway. Tromsø/Oslo: Norwegian Government; 2011.
- Seppälä S, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997;337:441–4.
- Aspinall SL, Metlay JP, Maselli JH, Gonzales R. Impact of hospital formularies on fluoroquinolone prescribing in emergency departments. Am J Manag Care 2007;13:241–8.
- Cizman M, Srovin T, Pokorn M, Cad Pecar S, Battelino S. Analysis of the causes and consequences of decreased antibiotic consumption over the last 5 years in Slovenia. J Antimicrob Chemother 2005;55:758–63.
- Sandvik H, Hunskår S. Årsstatistikk fra legevakt 2008 og 2009. Rapport nr. 7-2010 (Annual statistical report from Norwegian primary care out-of-hours services 2008–09). Bergen: Nasjonalt Kompetansesenter for Legevaktmedisin, Uni Helse; 2010.
- World Health Organization. WHO Collaborating Centre for Drug Statistics Methodology (2006). ATC Index with DDDs 2007. Oslo, Norway: WHO Collaborating Centre; 2007. Available at: http://www.whocc.no/atc_ddd_index/ (accessed September 2013).
- Brookes-Howell L, Hood K, Cooper L, Little P, Verheij T, Coenen S, et al. Understanding variation in primary medical care: a nine-country qualitative study of clinicians’ accounts of the non-clinical factors that shape antibiotic prescribing decisions for lower respiratory tract infection. BMJ Open 2012;2.
- Price D. Impact of antibiotic restrictions: the physician's perspective. Clin Microbiol Infect 2006;12(Suppl 5):3–9.
- Antoniadou A, Kanellakopoulou K, Kanellopoulou M, Polemis M, Koratzanis G, Papademetriou E, et al. Impact of a hospital-wide antibiotic restriction policy program on the resistance rates of nosocomial Gram-negative bacteria. Scand J Infect Dis 2013;45:438–45.
- Buising KL, Thursky KA, Robertson MB, Black JF, Street AC, Richards MJ, et al. Electronic antibiotic stewardship— reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital setting. J Antimicrob Chemother 2008;62:608–16.
- Grimshaw J, Eccles M, Thomas R, MacLennan G, Ramsay C, Fraser C, Vale L. Toward evidence-based quality improvement. Evidence (and its limitations) of the effectiveness of guideline dissemination and implementation strategies 1966–1998. J Gen Intern Med 2006;21(Suppl 2):S14–20.
- Hasty M, Schrager J, Wrenn K. Physicians’ perceptions about managed care restrictions on antibiotic prescribing. J Gen Intern Med 1999;14:756–8.
- Doron S, Davidson LE. Antimicrobial stewardship. Mayo Clin Proc 2011;86:1113–23.